ALLOS THERAPEUTICS INC 4
4 · ALLOS THERAPEUTICS INC · Filed Feb 27, 2012
Insider Transaction Report
Form 4
BENNETT BRUCE K JR
VP, Manufacturing
Transactions
- Sale
Common Stock
2012-02-23$1.58/sh−4,484$7,085→ 111,041 total - Sale
Common Stock
2012-02-24$1.55/sh−1,469$2,277→ 109,572 total
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan under which Mr. Bennett sold a portion of his holdings for tax and estate planning purposes.
- [F2]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $1.5800 to $1.5801. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.